Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    Alpha-GPC molecular structure

    Alpha-GPC Stats & Data

    Alfa-gpc Choline alfoscerate L-alpha glycerylphosphorylcholine
    NPS DataHub
    MW257.22
    FormulaC8H20NO6P
    CAS28319-77-9
    IUPAC[(2R)-2,3-dihydroxypropyl] 2-trimethylazaniumylethyl phosphate
    SMILESOCC(O)COP(=O)([O-])OCC[N+](C)(C)C
    InChIKeySUHOQUVVVLNYQR-MRVPVSSYSA-N
    Chemical Class Choline derivative

    Pharmacology

    DrugBank
    State Solid

    Description

    A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids. (From Stedman, 26th ed) It counteracts the effects of urea on enzymes and other macromolecules. PubChem

    Receptor Profile

    Receptor Actions

    Other
    Precursor to choline and glycerophosphate in the brain
    increases acetylcholine synthesis and release via enhanced choline availability
    supports phospholipid biosynthesis and cell membrane integrity

    Experience Report Analysis

    Erowid
    1 Reports
    0 Single-substance
    2013–2013 Date Range
    1 With Age Data

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 1 report, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 1 of 1

    Age Distribution

    Reports Over Time

    Real-World Dose Distribution

    Erowid

    From 10 of 10 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.

    Oral (n=10)

    Median: 400.0mg 25th: 300.0mg 75th: 600.0mg 90th: 600.0mg
    ← Back to Alpha-GPC